HER2-positive metastatic breast cancer is a particularly challenging and aggressive form of the disease. It’s driven by an overproduction of the HER2 protein, which accelerates tumour growth and promotes its spread to other parts of the body. But there’s a silver lining. Recent advances in medical research and treatment are offering new hope.
